Ascab

Ascab1.25 gm/5 ml

Lotion

Benzyl Benzoate

Hudson Pharmaceuticals Ltd.

Product Code : 1403
MRP 12.13
10% Off
Best PriceTk
/
Out Of Stock
1
Section

Medicine overview

Indications of Ascab 1.25 gm/5 ml

Ascab 1.25 gm/5 ml is indicated for scabies

Theropeutic Class

Parasiticidal preparations, Topical Antifungal preparations

Pharmacology

Benzyl benzoate is an acaricide that is used in the treatment of scabies. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, Ascab 1.25 gm/5 ml has been found to kill the Sarcoptes mite within 5 minutes.

Dosage & Administration of Ascab 1.25 gm/5 ml

Adult: Apply 3 times at 12 hourly intervals over the whole body, wash-off 12 hr after the last application.

Dosage of Ascab 1.25 gm/5 ml

Adult: Apply 3 times at 12 hourly intervals over the whole body, wash-off 12 hr after the last application.

Interaction of Ascab 1.25 gm/5 ml

Irritant to eyes and mucous membranes, allergic dermatitis reactions, drying effects in the elderly.

Contraindications

Broken or irritated skin; neonates; pregnancy.

Side Effects of Ascab 1.25 gm/5 ml

Irritant to eyes and mucous membranes, allergic dermatitis reactions, drying effects in the elderly.

Pregnancy & Lactation

Pregnancy Category: Not Classified. FDA has not yet classified the drug into a specified pregnancy category.

Precautions & Warnings

Prevent drug from entering the eyes, elderly (drying effects).

Storage Conditions

Store below 25°C.

Drug Classes

Parasiticidal preparations, Topical Antifungal preparations

Mode Of Action

Benzyl benzoate is an acaricide that is used in the treatment of scabies. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, Ascab 1.25 gm/5 ml has been found to kill the Sarcoptes mite within 5 minutes.

Pregnancy

Pregnancy Category: Not Classified. FDA has not yet classified the drug into a specified pregnancy category.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.